Atrial fibrillation signals associated with overactive bladder drugs across JADER and FAERS: disproportionality and time-to-onset analyses.

Nagura K, Watanabe S, Watanabe T, Sagara H

Open source

DOI
10.3389/fphar.2025.1700587
Published
2025
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2025.1700587,
  title = {Atrial fibrillation signals associated with overactive bladder drugs across JADER and FAERS: disproportionality and time-to-onset analyses.},
  author = {Nagura K and Watanabe S and Watanabe T and Sagara H},
  year = {2025},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2025.1700587},
  url = {https://doi.org/10.3389/fphar.2025.1700587}
}

RIS

TY  - JOUR
TI  - Atrial fibrillation signals associated with overactive bladder drugs across JADER and FAERS: disproportionality and time-to-onset analyses.
AU  - Nagura K
AU  - Watanabe S
AU  - Watanabe T
AU  - Sagara H
PY  - 2025
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2025.1700587
UR  - https://doi.org/10.3389/fphar.2025.1700587
ER  - 

APA

K, N., S, W., T, W., & H, S. (2025). Atrial fibrillation signals associated with overactive bladder drugs across JADER and FAERS: disproportionality and time-to-onset analyses.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2025.1700587

Source records